Top Markets
#1 Audiera Audiera +35.09%
#2 GALA GALA +33.70%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.94%
#4 Bitcoin Cash Bitcoin Cash +32.75%
#5 Fabric Protocol Fabric Protocol +32.18%
#6 Tutorial Tutorial +30.33%
#7 Zora Zora +29.59%
#8 Bless Bless +29.29%
#9 Arowana Arowana +28.17%
#10 Pepe Pepe +26.40%
Coin of the day
Audiera Audiera
設定
言語
日本
通貨
USD
テーマ
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
株式のランク #24695
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
株価
$0.95011029
最終同期: 2023-06-28
時価総額
$57.72M
変化（1日）
8.53%
変化（1年）
0.00%
国
FR
取引 ERYTECH Pharma S.A. (ERYP)

カテゴリー

Healthcare
ERYTECH Pharma S.A.（ERYP）の利益
2026 時点の利益 TTM: 0
ERYTECH Pharma S.A. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
ERYTECH Pharma S.A. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH